Home › Amyloidosis › Wisconsin
Amyloidosis clinical trials in Wisconsin
3 studies for Amyloidosis are looking for participants at sites in Wisconsin.
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- University of Wisconsin - Madison, Madison
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Nov 4, 2026 · NCT06128629Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Milwaukee
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Wisconsin Medical Center /ID# 255836, Milwaukee
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT06158854From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.